16 May, 2013 / "SensiDerm Assay Could fill Void for Non-Animal Allergy Test in EU" - The Rose Sheet The Rose Sheet, Hales Proteome Sciences SensiDerm Multiplex Assay as a solution to the Animal Testing Void in EU.
Read More

14 May, 2013 / Proteome Sciences featured in Time Magazine- "Breakthrough Blood Work" These new proteomic-derived agents are designed to target everything from sepsis to Alzheimer’s disease to cancer and offer the opportunity to deliver bespoke medicine, tailored to your molecular structure. It’s Savile Row biology.
Read More

11 May, 2013 / Blood Test-A Simple Diagnosis for Alzheimer's? The National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC) for Mental Health, in collaboration with Proteome Sciences and Merck Millipore, has successfully concluded a 1,000 sample Alzheimer’s disease biomarker validation study.
Read More

01 May, 2013 / SensiDerm™ Animal Replacement Assays Selected By Cosmetics Europe COLIPA has just selected the SensiDerm™ multiplex assays by Proteome Sciences in the first priority set of tests. Funding is available from Cosmetics Europe and the EU for further development of the priority tests. 
Read More

18 Apr, 2013 / New Product Announcement: Alzheimer's CSF 16-Plex Proteome Sciences has developed a novel biomarker panel for simultaneous measurement of 16 signature protein biomarkers in Alzheimer Disease.
Read More

18 Mar, 2013 / Developments in Alzheimer's Disease Proteome Sciences presented four posters that revealed new data and assays in Alzheimer’s disease (AD) at the 11th Annual Conference on Alzheimer’s and Parkinson’s Disease (ADPD) in Florence, Italy. 
Read More